Light Mode
$9.75 ↑ +0.75 (+8.33%) Trading Up from the previous close of $9.00, $0.04 below the day’s high of $9.79
+9.42 (+2881.65%) / 6M
Momentum, market sentiment, and recent alerts
CFOR reads n/a: the 12-month move is -60.2%.
No alerts for CFOR in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
CapForce, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.